Cargando…
The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with increasing incidence and high mortality. Surgical resection is the only potentially curative treatment of patients with PDAC. Because of the late presentation of the disease, about 20 percent of patients are candidates for this...
Autores principales: | Hawa, Zuhair, Haque, Inamul, Ghosh, Arnab, Banerjee, Snigdha, Harris, LaCoiya, Banerjee, Sushanta K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926343/ https://www.ncbi.nlm.nih.gov/pubmed/27240340 http://dx.doi.org/10.3390/ijms17060809 |
Ejemplares similares
-
miRacle of microRNA-Driven Cancer Nanotherapeutics
por: Kara, Goknur, et al.
Publicado: (2022) -
Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire?
por: Li, Jin, et al.
Publicado: (2013) -
Cellular microRNA detection with miRacles: microRNA- activated conditional looping of engineered switches
por: Chandrasekaran, Arun Richard, et al.
Publicado: (2019) -
Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway
por: Haque, Inamul, et al.
Publicado: (2018) -
Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth
por: Das, Amlan, et al.
Publicado: (2017)